Physician profile
Catherine Sipe
NPI 1184603854
$1,577.31
in general payments reported to CMS, 2019-2025
18 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $241 · 2021: $244 · 2022: $202 · 2023: $151 · 2024: $227 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514 · Long Term Medical Supply Or Device Loan: $22.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.83 |
| Long Term Medical Supply Or Device Loan | $22.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $391.22 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $274.55 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Takeda Pharmaceuticals U.S.A., INC. | $176.86 | 2020-2022 | |
| Glaxosmithkline, LLC. | $170.10 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Supernus Pharmaceuticals, INC. | $99.71 | 2021-2024 | Qelbree |
| Sanofi-Aventis U.S. LLC | $83.49 | 2025 | |
| Sanofi Pasteur INC. | $64.70 | 2023-2024 | |
| Tris Pharma INC | $64.19 | 2019-2025 | Dyanavel Xr |
| Corium, LLC | $51.21 | 2023-2024 | Azstarys |
| Cranial Technologies, INC | $43.87 | 2019-2024 | Doc Band |
| Shire North American Group INC | $28.54 | 2019 | |
| Baxter Healthcare | $22.08 | 2024 | Hillrom - Spot Vision Screener |
| Verrica Pharmaceuticals INC. | $21.87 | 2024 | Ycanth |
| Sobi, INC | $20.85 | 2022 | |
| Seqirus USA INC | $18.79 | 2024 | Flucelvax |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $16.80 | 2025 | Immunocap |
| Ironshore Pharmaceuticals INC. | $14.26 | 2019 | |
| Adlon Therapeutics L.P. | $14.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Sipe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.